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Adipocyte differentiation is a complex process regulated among other factors by insulin and the production of reactive oxygen species (ROS).
NOX4 is a ROS generating NADPH oxidase enzyme mediating insulin′s action in 3T3L1 adipocytes. In the present paper we show that NOX4 is
expressed at high levels both in white and brown preadipocytes and that differentiation into adipocytes results in a decrease in their NOX4 mRNA
content. These in vitro resultswere confirmed in vivo by demonstrating that in intact adipose tissue themajority ofNOX4expressing cells are localized
within the preadipocyte containing stromal/vascular fraction, rather than in the portion consisting ofmature adipocytes. In linewith these observations,
quantification of NOX4mRNA in fat derived from different rodent models of insulin resistance indicated that alteration in NOX4 expression reflects
changes in the ratio of adipocyte/interstitial fractions. In conclusion, we reveal that decreased NOX4 mRNA content is a hallmark of adipocyte
differentiation and that NOX4 expression measured in whole adipose tissue is not an unequivocal indicator of intact or impaired insulin action.
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cules that are generated during physiological cellular metabolic
processes as well as under various stress conditions [1]. Excess,
uncontrolled production of oxygen radicals is involved in the
development of insulin resistance [2–7]. By contrast, tightly
regulated and targeted ROS production is an essential
component of insulin signaling [8–13]. The major sources of
ROS production within the cell are the mitochondria, different
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doi:10.1016/j.bbamcr.2007.03.003oxidases [1,14]. The classical NADPH oxidase isoform (gp91-
phox/NOX2) is found in phagocytes and is involved in bacterial
killing. Recently several homologues of NOX2 have been
described, but their function and regulation is still poorly
understood [14]. NOX1 is present in colon epithelial cells,
NOX3 in human embryonic kidney and mouse inner ear, while
expression of NOX5 has been shown to be restricted to the testis
and lymphatic tissues. NOX4, originally termed “renox”, is most
highly expressed in the kidney [15]. However, more recently
NOX4 expression has been demonstrated in other tissues and
cell types, including diverse embryonic tissues [16], vascular
smooth muscle (VSMC) and endothelial cells [17,18], melano-
cytes [19], osteoclasts [20], hepatocytes [21], cardiac fibroblasts
[22], adipocytes [23] and corneal cells [24]. It has been
suggested that in these cells NOX4 is involved in cell cycle
Fig. 1. Detection of NOX4 mRNA in mouse tissues and human adipose tissue
fractions. (A) RT-PCR shows detectable levels of NOX4 expression in all insulin
responsive tissues. Total RNA was prepared using TRIZOL Reagent (Invitro-
gen, Basel, Switzerland) or Ultraspec RNA Isolation System (Biotecx, Houston,
TX) and 2 μg of DNA-free RNA was reverse-transcribed by Superscript II
Reverse Transcriptase (Invitrogen, Basel, Switzerland). Mouse NOX4 primers
and PCR conditions were as described in [30]. WAT: white adipose tissue, BAT:
brown adipose tissue RT+: sample with reverse transcription reaction, RT−:
sample without reverse transcription. H2O denotes PCR reaction devoid of
template cDNA. (B) Real-time PCR quantification of NOX4 expression in
mouse tissues relative to the amount of 18S rRNA. Primers, conditions and the
method of quantification were identical to [30] and are listed in Table 1. Results
are shown as percentage of the expression in kidney. (C) NOX4 expression is
localized in the stromal fraction of human adipose tissue. Human subcutaneous
adipose tissue was obtained from surgical specimens of patients undergoing
plastic surgery with the authorization of the Ethical Commission of the
University Hospitals of Geneva and the Centre Hospitalier Universitaire
Vaudois, Switzerland and the informed consents from the patients. Separation of
the stromal/vascular fraction from adipocytes was carried out by digesting 0.6 g
adipose tissue with type 1 collagenase (Worthington Biochemical Corporation,
Lakewood, USA) (600 U/g adipose tissue) in low glucose DMEM containing
penicillin and streptomycin, as well as the bovine albumin fraction V (20 mg/ml)
(Sigma, Buchs, Switzerland) at 37 °C in a rocking bath. After 30 min of
incubation, the digestion was stopped by the addition of FBS (0.3 ml/ml
digestion medium). Adipocytes and the stromal fraction were then separated
from undigested tissue by filtration through a 350 μm nylon mesh and
centrifugation (10 min at 200×g). Adipocytes were resuspended in 2 ml of low
glucose DMEM (10% FBS, glutamine 200 mM and 1% penicillin and
streptomycin). The pellet containing the stromal fraction was resuspended in
low glucose DMEM containing 10% FBS, 1% glutamine and 1% penicillin and
streptomycin to promote cell adhesion. 24 h after plating, the medium was
changed and cells were grown for 4 days before lysis and RNA preparation.
NOX4 expression was mainly localized in the stromal/vascular fraction as
assessed by RT-PCR. Tie 2 PCR indicates the presence of endothelial cells. β-
actin expression was amplified to verify mRNA integrity, and equal rate of
cDNA synthesis and input in all fractions. H2O signifies PCR reaction lacking
cDNA. The primers for human NOX4, Tie 2 and β-actin are listed in Table 1.
Table 1
RT-PCR and real-time PCR primers used in this study
Primer RT-PCR Sequences of forward (F) and reverse (R) primers
NOX1 mouse TGAACAACAGCACTCACCAATGCC(F)
TCATTGTCCCACATTGGTCTCCCA(R)
NOX2 mouse TGTCATTCTGGTGTGGTTGG(F)
CCCCTTCAGGGTTCTTGATT(R)
NOX3 mouse TTGTGGCACACTTGTTCAACCTGG(F)
TCACACGCATACAAGACCACAGGA(R)
NOX4 mouse CCTCATGGTTACAGCTTCTACCTACGC(F)
TGACTGAGGTACAGCTGGATGTTCAC(R)
NOX4 human AGGAGAACCAGGAGATTGTTGGATAAA(F)
ATCTGAGGGATGACTTATGACCGAAAT
Tie 2 human CCTTAATGAACCAGCACCAGG(F)
ACTTCTGGGCTTCACATCTCCG(R)
β-Actin human ATGGGTCAGAAGGATTCCTATGT(F)
GAAGGTCTCAAACATGATCTGGG(R)
DUOX1 mouse TGTCAGGCTACGAGATGGTG(F)
GTTGCTGGACAGGATGAGGT(R)
DUOX2 mouse GCCAGCTGCCATGGATGATG(F)
CATAGCTGCCATGGATGATG(R)
Cyclophillin mouse GAGCTGTTTGCAGACAAAGTTCCA(F)
ATCTTCTTGCTGGTCTTGCCATTC(R)
Primer Real-time PCR Sequences of forward (F) and reverse (R) primers
NOX4 mouse TTGCCTGGAAGAACCCAAGT(F)
TCCGCACAATAAAGGCACAA(R)
Cyclophillin mouse CAAATGCTGGACCAAACACAA(F)
GCCATCCAGCCATTCAGTCT(R)
p22phox mouse TGCCCTCCACTTCCTGTT(F)
GCAGATAGATCACACTGGCAAT(R)
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Importantly, NOX4 has been shown to produce H2O2 con-
tinuously in NOX4 overexpressing HEK293 cells and endothe-
lial cells [15,25,26]. Moreover, increased activity of NOX4 has
been linked to elevated NOX4 mRNA expression levels in vivo
[15,22,25], while a decrease in activity was associated with a
downregulation of its expression [27]. Thus, the regulation of
NOX4 transcription is an important step in modulating NOX4
activity. In murine 3T3L1 adipocytes NOX4 has been shown to
be essential for proper insulin receptor phosphorylation and
insulin-induced glucose transport, while in human skin
fibroblasts the lack of NOX4 resulted in decreased PDGF and
EGF receptor phosphorylation [23,27]. By contrast, increased
whole adipose tissue NOX4 expression has been linked to
oxidative stress and insulin resistance [28]. Therefore, the goal
of our study was to gain a better insight in the relationship
between NOX4 expression and insulin signaling in vitro and in
vivo. Since insulin is an important regulator of adipogenesis, we
have characterized the changes in NOX4 expression during
brown and white adipocyte differentiation in vitro and in the
adipose tissues of rodent models of altered insulin signaling in
vivo.
The NADPH oxidase isoform NOX4 has been identified in
the kidney by Northern blot analysis [15]. To evaluate the
expression of NOX4 in insulin responsive tissues by a more
sensitive method we performed RT-PCR and real-time quanti-
tative PCR analysis using mouse brain, muscle, liver, and white
and brown adipose tissues (Fig. 1A and B, respectively). All
tissues examined showed expression of NOX4 mRNA.
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the muscle, liver and the white and brown adipose tissues was
between 2 and 8% of that of the kidney, explaining the lack of
detection by Northern-blot analysis. White and brown adipose
tissue showed similar quantities of NOX4 mRNA expression.
To identify the NOX4 containing cells within the adipose tissue
we separated the stromal–vascular and adipocyte fraction
derived from explants of human subcutaneous fat depot.
Semiquantitative RT-PCR detected high levels of NOX4
expression in the total explant. However, upon separation of
adipocytes from the preadipocyte/stromal/vascular fraction,
NOX4 was predominantly found in the latter part with only
marginally detectable levels in adipocytes. As the stromal
fraction contains endothelial cells known to express NOX4 we
assessed the mRNA levels of the endothelial cell specific
receptor Tie 2 in the same three fractions. High expression of
Tie 2 was detected in the intact explant, but was diminished in
the isolated stromal fraction under tissue culture conditions. By
contrast, NOX4 mRNA was readily detected in this fraction
indicating the presence of other NOX4 expressing cells most
likely fibroblasts and pre-adipocytes dominating the culture
over the endothelial cells (Fig. 1C).
To further localize the expression of NOX4 in intact white
adipose tissue we performed in situ hybridization and
immunohistochemical staining for NOX4. The NOX4 antisense
probe strongly marked the stromal areas (Fig. 2A, left panel),
while there was no signal detected when hybridized with the
sense probe (Fig. 2A, right panel). Localization was confirmed
and refined by immunohistochemistry, where arteriole walls,
capillaries, stromal fibroblasts/preadipocytes showed clear
staining with only a weak signal present in the adipocytes
(Fig. 2B, left panel). The rabbit polyclonal anti-NOX4 antibodyFig. 2. Localization of NOX4 expressing cells in mouse white and brown adipos
expression mainly in cells within the stromal fraction of white adipose tissue (left pan
sense probe (right panel, sense probe). (B) Immunohistochemical detection using ant
Weaker signal is present in adipocytes (left panel, NOX4 antibody). The specificity of
in our previous publication [30]. Absence of reaction upon omission of the primary an
detects NOX4 expression in brown adipocytes (left panel, antisense probe) and lack
Immunohistochemical staining with NOX4 antibody showing labelling in brown a
Omission of the first antibody results in the ablation of staining (right panel, controused in these experiments has been shown to be specific for
NOX4 and in a previous study we have successfully applied it
on mouse histochemical sections [29,30]. No staining was
obtained in the absence of primary antibody (Fig. 2B, right
panel). Brown adipose tissue shares several molecular char-
acteristics with the white adipose tissue but their functions are
distinct. To examine the adipose tissue specificity of NOX4
expression we performed the same experiments on mouse
brown adipose tissue slides. As shown in Fig. 2C and D, images
similar to those seen in white adipose tissue sections were
observed: adipocytes and stromal elements were strongly
labelled with the NOX4 antisense probe (Fig. 2C, left panel)
but no signal was obtained when hybridized with the sense
probe (Fig. 2C, right panel). Immunohistochemical staining
showed a corresponding picture with clear labelling both in
brown adipocytes and the stroma, while omission of the first
antibody resulted in the lack of detectable signal (Fig. 2D left
and right panels, respectively).
The isolated stromal fraction of human adipose tissue, where
RT-PCR revealed high level of NOX4 expression, contains
preadipocytes capable to differentiate into adipocytes. In
addition, we detected similar stromal localization of NOX4
expression in intact white and brown adipose tissues. To
determine if a relationship between NOX4 and adipogenesis
exits, we first decided to investigate the expression of the
members of the NOX enzyme family during differentiation in
two well-characterized fat cell lines: the 3T3L1 mouse white
adipose cell line and in an immortalized mouse brown adipose
cell line [31]. As shown by semiquantitative RT-PCR only
NOX4 showed identical differentiation-related changes in both
white and brown adipose cells with a high expression level in
preadipocytes and a decreased expression in differentiatede tissues. (A) In situ hybridization with NOX4 antisense probe shows NOX4
el, antisense probe). No signal is obtained when staining is performed using the
iNOX4 antibody shows strong staining in vascular cells and stromal fibroblasts.
the antibody has been demonstrated in NOX4 siRNA knock-down cells [29] and
tibody (right panel, control). (C) In situ hybridization with NOX4 antisense probe
of signal when labelling with NOX4 sense probe (right panel, sense probe). (D)
dipocytes and the surrounding white adipocytes (left panel, NOX4 antibody).
l).
Fig. 3. NOX enzyme expression in 3T3L1 and wild type brown adipocytes (BAT
WT) upon differentiation. Only NOX4 displays similar differentiation-related
decrease in 3T3L1 and brown adipose cells. The PCR primers used are listed in
Table 1. Pre-A=preadipocytes, A=adipocyte, RT− signifies PCR reaction
devoid of reverse transcription, and H2O marks PCR reaction devoid of added
cDNA. +C signifies positive control reaction: mouse cDNA prepared from colon
for NOX1, spleen for NOX2, kidney for NOX4, cerebellum for DUOX1 and
colon for DUOX2. NOX3 PCR was performed using the primers as in [54] but
no positive control mouse inner ear cDNA could be obtained. Amplification of
cyclophillin serves as control for cDNA integrity.
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expression in adipogenesis we first examined the mRNA and
protein expression of this enzyme in 3T3L1 cells by real-time
PCR, conventional RT-PCR and Western blot analysis.
Differentiation of 3T3L1 preadipocytes was induced using a
standard protocol by a cocktail containing 1 μg/ml insulin,
0.25 μM dexamethasone and 0.5 mM isobutylmethylxanthane
(IBMX) for 96 h. Thereafter cells were cultured in high-glucose
DMEM supplemented with 1 μg/ml insulin, 10% FBS and
penicillin–streptomycin and were used between days 10 and 12.
Real-time PCR detected high level of NOX4 expression in
confluent preadipocytes, which then decreased significantly by
the end of the induction stage (day 4), and further declined in the
fully differentiated adipocytes (days 10–12) (Fig. 4A, upper
panel). In the a human lung cancer cell line, four isoforms of
NOX4 have been described with different expression levels and
ROS producing capacity, but their physiological function and
regulation have not been further examined [32]. Conventional
RT-PCR reactions performed with primers designed to detect a
potential differentiation-induced change in isoform expression
revealed only one transcript for NOX4, thus argues against a
hypothetical switch between the full length and the truncated
dominant negative NOX4 transcripts (Fig. 4A, lower panel). To
assess the changes in NOX4 protein amount we performed
Western blot analysis using a rabbit polyclonal anti-NOX4
antibody that has been successfully employed to monitor
siRNA mediated NOX4 gene knock-down in mouse embryonic
bodies [33]. Quantification of the blots confirmed that NOX4
protein levels were diminished during adipogenesis mirroring
the alterations in mRNA transcription (Fig. 4B).
Brown preadipocytes may be induced to undergo a
differentiation process similar in several aspects to that of
white preadipocytes. To assess if NOX4 mRNA expression is
regulated during brown adipogenesis, we compared NOX4mRNA levels in undifferentiated and differentiated state using
immortalized brown preadipocytes derived from different
insulin receptor substrate (IRS) knock-out mice. Differentiation
of confluent dishes of brown preadipocytes was induced by
supplementing the differentiation medium (high glucose
DMEM supplemented with 10% FBS and penicillin–strepto-
mycin, 20 nM insulin and 1 nM 3,3,5-triiodo-L-thyronine (T3))
with 0.5 mM isobutylmethylxanthin (IBMX), 0.5 μM dexa-
methasone and 0.125 mM indomethacin for 48 h. Then cells
were placed back to differentiation medium for 96 h and were
used for experimentation [31]. These various IRS knock-out
brown adipose cell lines are known to exhibit divers capacity to
differentiate into mature adipocytes with the decreasing order of
wild type, IRS-4 KO, IRS-2 KO, IRS-3 KO and IRS-1KO cells
[31]. As assessed by real-time PCR and RT-PCR analysis in the
undifferentiated stage all cell lines expressed high amount of
NOX4. In those cells which differentiated, (WT, IRS-2 and IRS-
4 KO) NOX4 mRNA levels declined dramatically (60–80%)
upon differentiation. By contrast, NOX4 expression levels
remained high in those cell lines which displayed reduced
differentiating capacity (IRS-1 and IRS-3 KO) (Fig. 4C, upper
panel). None of the cell lines exhibited altered NOX4 isoform
expression as judged by conventional RT-PCR (Fig. 4C, lower
panel). Thus, similar to the process observed during white
adipocyte differentiation, brown adipose cell lines display again
a tight inverse correlation between their NOX4 mRNA levels
and their degree of differentiation. By contrast, differentiation-
related changes in NOX4 mRNA and protein levels were less
coordinated in brown adipocytes than in 3T3L1 cells. All brown
adipose cell lines displayed high NOX4 protein expression in the
undifferentiated state. This high expression was significantly
downregulated both in the wild type and in all the various IRS
knock-out cell lines when cells were subjected to the standard
differentiation protocol (Fig. 4D). This apparent discrepancy
between the regulation of NOX4 mRNA and protein levels
suggests a more complex regulatory mechanism compared to
3T3L1 adipocytes. Of specific interest is the explicit opposite
regulation of NOX4 mRNA and proteins levels in the IRS-3
knock-out cells arguing for a multifaceted regulatory pathway
possibly involving a feed-back regulatory mechanism in these
cells. Indeed, a similar contradictory regulation can be observed
in the expression of IRS-2 in differentiating wild type brown
adipocytes where a decline in IRS-2 mRNA expression is
accompanied by an elevation in protein expression, likely
through an alternative regulation of IRS-2 protein by the
proteasome pathway [31,34]. Stabilization and maturation of the
NOX4 homologue molecules NOX2 and NOX3 is highly
dependent on the presence of p22phox, a membrane bound
component of several NOX enzyme complexes [35–37]. In
addition, p22phox mRNA levels exhibited parallel changes to
NOX4 mRNA expression in the white adipose tissue of the
insulin resistant KKAymice and in the kidney of Streptozotocin-
induced diabetic rats [28,38]. In our study we did not observe a
statistically significant differentiation-dependent change in
p22phox mRNA expression in any of the cells studied (data not
shown). Whether some other brown adipocyte specific post-
transcriptional regulatory pathway is responsible for the
Fig. 4. NOX4 expression is down-regulated in differentiated 3T3L1 and brown adipocytes. (A) Upper panel: downregulation of NOX4 expression during white
adipocyte differentiation. Real-time PCR quantification of NOX4mRNA expression in 3T3L1 preadipocytes (day 0), at the end of the induction phase (day 4) and after
complete differentiation (days 10–12). NOX4 mRNA levels are shown as arbitrary units relative to the expression in preadipocytes. Lower panel: semiquantitative RT-
PCR detection of NOX4 in 3T3L1 preadipocytes and differentiated adipocytes. H2O represents PCR reaction in the absence of cDNA. (B) NOX4 protein amount is
down-regulated during differentiation. Upper panel: Quantification of NOX4 protein expression in 3T3L1 adipocytes. Signal intensity was quantified by ChemiDoc
software (Biorad). Protein expression is shown as the NOX4 protein amount relative to actin and is expressed as arbitrary unit compared to preadipocytes. Lower
panel: Representative Western blot of 3T3L1 cells before and after the induction of differentiation. Equal protein charge was verified by blotting with an anti-actin
antibody. The specificity of the rabbit polyclonal anti-NOX4 antibody was previously demonstrated in NOX4 knock-down cells [33]. (C) Upper panel: downregulation
of NOX4 expression during brown adipocyte differentiation. Real-time PCR analysis of NOX4 expression in wild type (WT) and different IRS protein (IRS1–4)
knock-out brown adipocyte cells before (solid bars) and after (empty bars) differentiation. Results are expressed as arbitrary units compared to NOX4 expression in
wild type preadipocytes. Lower panel: semi-quantitative RT-PCR detection of NOX4 expression in the same cell lines in non-differentiated and differentiated state.
H2O signifies PCR reaction lacking cDNA. Real-time PCR and RT-PCR reactions were carried out as described previously [30], the primers are listed in Table 1. (D)
Western blot analysis of NOX4 protein expression in non-differentiated and differentiated wild type and diverse IRS protein knock-out brown adipose cell lines. Upper
panel: quantitative analysis of NOX4 protein expression relative to actin and expressed as arbitrary units compared to the expression in wild type cells. Lower panel:
representative Western blot for NOX4 and actin. Anti-NOX4 antibody was identical as in Fig. 4B.
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is an intriguing question and should be addressed in a detailed
fashion in further studies with a special emphasis on the role of
IRS-3, most abundantly expressed in the adipose tissue.
Taken all the above data together, they suggest that NOX4 is
expressed at high levels in white and brown preadipocytes and
that its mRNA and protein expression is subjected to a tight and
complex regulation during adipogenesis. Moreover, expression
of NOX4 or the lack of it might modify insulin receptor signaling
in related cell types such as preadipocytes and adipocytes, and be
an important regulatory element in mediating insulin′s effect oncell differentiation in cells with low levels of insulin receptor
expression. In support of a role for NOX4 in adipocyte
differentiation, a recent study reported the downregulation of
NOX4mRNA in endothelial cells in response to PPARγ ligands,
agents known to be major regulators of adipocyte differentiation
[39]. In addition, as a more general aspect of cell differentiation
another study reported the requirement for NOX4 in regulating
vascular smooth muscle specific gene expression [40].
Studies conducted in 3T3L1 cells have demonstrated a link
between adipogenesis and ROS production [12,41]. NOX4 has
been shown to be constitutively active when overexpressed in
1020 S. Mouche et al. / Biochimica et Biophysica Acta 1773 (2007) 1015–1027HEK293 cells, and several studies have suggested that the
regulation of NOX4 expression is a major controller of NOX4
activity [15,25,26]. These data raise the possibility that changes
in NOX4 expression might be a link between adipogenesis andFig. 5. NADPH stimulates extracellular but not intracellular ROS production in 3T3L
(B) ROS production was recorded in preadipocytes (black circle) and adipocytes (gr
space using fluorescence assays. H2O2 released from the cells was measured by HRP
Peroxide/Peroxidase Assay kit). Intracellular release of ROS was measured by the me
diacetate acetyl ester (CM-H2DCFDA). Cells were starved for 14–16 h before measu
fluorescence of individual wells was measured for 5–10 min followed by the addition
Results are expressed as the percentage of 0 min production of the respective cells
independent experiments. (C) Extracellular and (D) intracellular ROS production in
(10 μM) or SOD (20 U/ml) and catalase (Cat) (100 U/ml). Results are expressed as the
and (F) intracellular ROS production in differentiated adipocytes in the presence ofproduction of reactive oxygen species. NOX4-related intracel-
lular ROS production has been detected by CM-H2DCFDA
fluorescence and nitroblue tetrazolium (NBT) reduction assays
[9,27,28,32]. More recently, NOX4-derived extracellular ROS1 preadipocytes and adipocytes. Spontaneous extracellular (A) and intracellular
ay circle). Reactive oxygen species were detected in the extra- and intracellular
-dependent oxidation of N-acetyl-dihydrophenoxanine (Amplex Red Hydrogen
mbrane permeable dye 5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein
rements. Plates were read in a thermostat controlled (37 °C) plate reader. Basal
of test compounds and fluorescence was recorded sequentially over a 2-h period.
and shown as mean±S.E.M., derived from triplicate measurements from 6 to 8
preadipocytes in the absence (control) or presence of NADPH (0.25 mM), DPI
percentage of production of non-treated (control) cells at 0 min. (E) Extracellular
NADPH, DPI or SOD and catalase.
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Peroxide/Peroxidase Assay Method [33]. Therefore we decided
to measure ROS production detectable in the intra- and
extracellular space in the absence or presence of different
stimulatory agents in 3T3L1 and wild type brown adipose cells
before and after differentiation looking for a relationship
between NOX4 expression and ROS production (Figs. 5A–F,
6A–F, 7A–F, and 8A–F, respectively).
First we characterized spontaneous ROS production in non-
differentiated and differentiated 3T3L1 cells and found striking
differences between preadipocytes and adipocytes, regarding
spontaneous free radical production. Preadipocytes showed aFig. 6. Fibroblast growth factor (FGF) induces extracellular, while insulin induce
Extracellular (A) and intracellular (B) ROS production was measured in preadipocyte
and 2 (1 nM). Results are shown after 120 min of stimulation and expressed as the
Student's t test, *p<0.05 vs. control, **p<0.01 vs. control, #p<0.05 vs. insulin stim
differentiated adipocytes using the same agents as in (A) and (B). Student's t test,
*&p<0.05 vs. FGF-1 stimulation. Inhibition of extracellular (E) and intracellular (F)
*p<0.05 vs. control, **p<0.01 vs. control, #p<0.05 vs. stimulated cells.moderate production of extracellular ROS but little accumula-
tion intracellularly. By contrast, adipocytes had a relatively
higher rate of spontaneous intra- and extracellular ROS
production compared to the preadipocytes (Fig. 5 A and B,
note also the different scale). This increased basal free radical
production in adipocytes is unexpected in view of the de-
creased NOX4 expression in these cells. Noteworthy, however,
that a similar increase in ROS production upon the depletion of
a NOX enzyme have been previously reported in NOX-3
siRNA knock-down HepG2 cells [42]. The extra- but not
the intracellular H2O2 generation was inducible by NADPH
(p<0.001 vs. control) pointing towards the differential in-s intracellular ROS production in both 3T3L1 preadipocytes and adipocytes.
s in the presence or absence of the insulin (100 nM), IGF-1 (100 ng/ml), FGF-1
percentage of control cells at 0 min. Statistical analysis was performed using
ulation. Extracellular (C) and intracellular (D) ROS production was measured in
*p<0.05 vs. control, **p<0.01 vs. control, #p<0.01 vs. insulin stimulation,
ROS production by DPI or SOD and catalase in preadipocytes and adipocytes.
1022 S. Mouche et al. / Biochimica et Biophysica Acta 1773 (2007) 1015–1027volvement of an NADPH oxidase enzyme in the two processes.
Spontaneous extracellular ROS production was unaffected by
the addition of the flavoprotein inhibitor DPI or the H2O2
scavangers catalase and superoxide dismutase (SOD) both in
preadipocytes (Fig. 5C and D) and in adipocytes as well (Fig.
5E and F). By contrast, intracellular free radical concentration
was enhanced by catalase and superoxide dismutase (SOD) in
both differentiation stages (Fig. 5D and F).
ROS production in 3T3L1 cells is inducible by a diverse
array of cytokines and growth factors which are also important
modulators of adipogenesis [41,43]. To assess the relationship
between ROS production and adipogenesis we compared free
radical production induced by these different stimuli, namely
fibroblast growth factors 1 and 2 (FGF-1 and FGF-2), insulin
and insulin-like growth factor 1 (IGF-1). When studying the
effects of FGF-1 and FGF-2 we found that both cytokines
increased extracellular H2O2 production, but with a signifi-
cantly higher magnitude in preadipocytes than in adipocytes
(Fig. 6A and C, respectively; also compare scales). This
difference can be readily explained by differences in FGF
receptor expression which is much greater in preadipocytes as
compared to adipocytes. By contrast, both FGFs affected
intracellular ROS generation in a contradictory fashion as they
inhibited insulin′s action in both cell types and blocked the low
amount of spontaneous production in preadipocytes (Fig. 6B
and D, respectively).
The importance of intracellular free radical generation has
been underlined by the data published recently by Mahadev et
al. who described a complex interaction between ROS
production and the classical insulin signaling pathways [44].
Using adenovirus mediated expression of dominant negative
NOX4 and siRNA transfections they argued that in differ-
entiated 3T3L1 adipocytes NOX4 mediates insulin induced
intracellular ROS production [23]. Our results also support the
formation of intracellular ROS upon insulin stimulation in
adipocytes. We found however, that preadipocytes actually
responded to insulin to a higher degree than adipocytes (Fig. 6B
and D, respectively). Insulin receptor expression is low in
preadipocytes and high in adipocytes [45], thus variances in the
number of receptors cannot account for this difference. In this
respect the data reported by Krieger-Bauer et al. is of special
interest as they described the presence of an H2O2 generating
system in human fat cells that was activated by insulin through a
mechanism bypassing the receptor kinase [11]. If a similar
mechanism links insulin stimulation and ROS generation in
preadipocytes is an intriguing possibility. It is also noteworthy
that while DPI blocked insulin stimulated ROS production in
preadipocytes it had no such effect in adipocytes (Fig. 6F).
Taken together all the above data they suggest an appealing
scenario where in preadipocytes an initial insulin-induced
“burst” in ROS production may trigger signaling events leading
to the initialization of the differentiation process and eventually
to the downregulation of NOX4 and the upregulation of insulin
receptor expression. Indeed, the tightly regulated timing of
insulin receptor expression was shown to be essential for
successful adipocyte generation as both insulin receptor
deficient and overexpressing preadipocytes failed to differenti-ate [43]. There are different observations concerning the exact
cellular localization of NOX4. It has been described to be
present in conjunction with focal adhesions and in the nucleus
in dedifferentiated rat vascular smooth muscle cells [46]. By
contrast, in differentiated muscle cells NOX4 showed a
prominent distribution along α-actin fibers [47]. Others
observed NOX4 in association with the membrane fraction in
rabbit corneal epithelial and stromal cells [24]. Thus NOX4-
mediated ROS could be released intracellularly triggering
adipogenesis in preadipocytes or extracellularly providing a
mean of communication between preadipocytes and other cells
such as endothelial cells or adipocytes. The signaling network
mediating the insulin-induced ROS production in preadipocytes
and its link to NOX4 is a worthy topic for future studies.
In our next set of experiments we characterizedROS production
in brown preadipocytes and adipocytes with a similar approach. In
contrast to 3T3L1 cells there was no difference in the rate of
spontaneous ROS production between brown preadipocytes and
adipocytes (Figs 7A and B, and compare to Fig. 5A and B).
Addition of NADPH selectively increased extracellular ROS
production, a feature similar to 3T3L1 cells, though the magnitude
of this effect was significantly lower (Fig. 7C–F and compare to
Fig. 5C–F). Addition of superoxide dismutase and catalase resulted
in a robust augmentation of intracellular ROS generation in
adipocytes likely reflecting enhanced mitochondrial superoxide
production. When investigating the effects of different growth
factors we noted that brown preadipocytes responded to different
stimuli to a much lesser degree compared to 3T3L1 preadipocytes
(Fig. 8A, B and E left panel) suggesting perhaps a less important
role of ROS generation in their initial differentiation program. This
finding is in line with other studies showing that in brown
adipocytes FGFs are potent mitogens but do not hamper
differentiation, by contrast they interfere with differentiation in
3T3L1 preadipocytes [41,48]. Brown adipocytes responded to
insulin with an increase and to norepinephrine with a decrease in
their ROS production. None of these two stimuli were sensitive to
DPImaking the involvement of anNADPHoxidase in these effects
unlikely (Fig. 8C–E right panel). Taken all the above data together,
they indicate the presence of a complex network of ROS
producing molecules in both 3T3L1 and brown adipocytes
preventing to determine a clear link between cellular NOX4
content and the observed spontaneous or induced ROS genera-
tion. In a previous study NOX4 activity in NOX4 overexpressing
cells was measured by the Amplex Red method and displayed
good correlation with NOX4 mRNA and protein levels [33]. In
our non-overexpressing cells we cannot confirm these data. In
line with our observation other studies used the oxidation of the
fluorescence dye dihydroethidiumbromide quantified by high
performance liquid chromatography to measure NOX4 related
intracellular superoxide release in primary human cardiac
fibroblasts and rat vascular smooth muscle cells [22,47]. Establish-
ing a direct connection between NOX4 expression and cellular
ROS production will be addressed in NOX4 knock-down
preadipocytes and adipocytes in our future experiments.
Obesity is closely linked to adipocyte differentiation and in
several but not all cases to insulin resistance [49–52]. Previous
studies favored a conclusion of associating elevated NOX4
Fig. 7. NADPH stimulates extracellular but not intracellular ROS production in brown preadipocytes and adipocytes. Spontaneous extracellular (A) and intracellular
(B) ROS production was recorded in preadipocytes (black circle) and adipocytes (gray circle) as described in Fig. 5. Results are expressed as the percentage of 0 min
production of the respective cells and shown as mean±S.E.M., derived from triplicate wells from 4 to 6 independent experiments. (C) Extracellular and (D)
intracellular ROS production in preadipocytes in the absence (control) or presence of NADPH, DPI or SOD and catalase (Cat). Results are expressed as the percentage
of production of non-treated (control) cells at 0 min. (E) Extracellular and (F) intracellular ROS production in differentiated adipocytes in the presence of NADPH, DPI
or SOD and catalase.
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relationship between NOX4 expression and adipocyte differ-
entiation and/or insulin resistance in vivo, we examined NOX4
mRNA levels in different animal models of altered insulin
receptor signaling using RT-PCR and quantitative RT-PCR.
Long-term (8 months) high fat diet feeding in mice resulted in
massive obesity with adipocyte hypertrophy and hyperplasia
and a significant decrease in NOX4 expression (Fig. 9A). Thislow level of NOX4 mRNA expression reflects a significantly
elevated adipocyte/stroma ratio compared to control mice.
Surprisingly, however, NOX4 protein expression was not
correlated with these results showing a sustained protein
amount despite lower mRNA levels (Fig. 9B). While the
exact mechanism of this stable NOX4 protein expression cannot
be explored in the frame of this study, these results suggest a
cell-specific, complex and multilevel regulation of NOX4
Fig. 8. Extra- and intracellular ROS production in non-differentiated and differentiated brown adipocytes in response to insulin, insulin-like growth factor 1 (IGF-1)
and fibroblast growth factor 1 and 2 (FGF-1 and FGF-2, respectively). Extracellular (A) and intracellular (B) ROS production was measured in preadipocytes in the
presence or absence of the different agents as marked. Results are shown after 120 min of stimulation and expressed as the percentage of control cells at 0 min.
Extracellular (C) and intracellular (D) ROS production was measured in differentiated adipocytes using the same agents as in (A) and (B). Statistical analysis was
performed using Student's t test, *p<0.05 vs. control. (E) Reversal of the effect of insulin and norepinephrine (10 μM) on intracellular ROS production by SOD and
catalase in non-differentiated and differentiated wild type brown adipocytes, *p<0.05 vs. control, **p<0.01 vs. control, #p<0.05 vs. insulin alone, * #p<0.001 vs.
norepinephrine alone.
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tional mechanisms in vivo.
To further explore a possible interaction between insulin
sensitivity and adipose tissue NOX4 expression we extended our
investigation to the well-characterized murine model of insulin
resistance, the leptin deficient ob/ob mice. In this model again
we found dissociation between NOX4mRNA and protein levels
with a three-fold increase in protein amount but no significant
change in mRNA expression (Fig. 9C and D). These observa-
tions are in agreement with previous data derived from another
model of insulin resistance, the mice carrying the obesity-related
agouti yellow mutation (KKAy mice). In these mice an increaseof NOX4 expression unrelated to the onset of diabetes was
described in 7-week-old obese, but not yet diabetic and in 13-
week-old obese and overtly diabetic mice as well [28].
The study mentioned above reported also an upregulation of
NOX4mRNA content in the white adipose tissue of high fat diet
fed mice as another model of insulin resistance [28]. As our
results (Fig. 9A) were obtained from mice with diet induced
obesity that were kept on high fat diet for an unusually long
period we decided to extend our investigations to shorter time
frames in order to better characterize the changes in NOX4
expression associated with short term metabolic challenges. To
reach this goal we analyzed NOX4 mRNA expression in the
Fig. 9. Differential regulation of NOX4 mRNA and protein expression in adipose tissue of mice with altered insulin signaling. (A) Obesity was induced in C57Bl6
male mice fed a high fat containing diet (4.31 kcal/g fat) for a period of 8 months. Control mice were fed a standard chow diet (3 kcal/g fat). The protocol was approved
by the Veterinary Office of the Canton of Geneva (Geneva, Switzerland). All mice had ad libitum access to water. Mice were sacrificed by decapitation and adipose
tissues were harvested and snap frozen in liquid nitrogen. NOX4 mRNA expression was assessed by quantitative real-time PCR. NOX4 values are normalized to
cyclophillin and expressed as arbitrary units compared to control diet fed littermates. n=4–6 mice/group, *p<0.05 vs. control. The image shows amplification of
NOX4 from the same mice by semiquantitative RT-PCR. H2O denotes PCR reaction devoid of added cDNA. (B) NOX4 protein expression in the white adipose tissue
of the same group of mice as in panel (A). The graph shows the quantification of NOX4 protein expression relative to that of actin. n.s.=non significant (p>0.05). The
image shows a representative Western blot of NOX4 and actin. (C) Nine-week-old ob/ob and control ob/+ male mice were purchased from Elevage J anvier (Le
Genest-St-Isle, France). NOX4 mRNA expression in the white adipose tissue was determined by real-time PCR and semiquantitative RT-PCR as in (A). n=6 mice/
group, n.s.=non-significant (p>0.05) as determined by Student's t test. (D) Quantification of NOX4 protein in the white adipose tissue of the same group of ob/ob and
ob/+ mice as in (C). **p<0.01 as determined by Student's t test. (E) Quantification of NOX4 mRNA by real-time PCR in the white adipose tissue of C56Bl6 male
mice fed a high fat containing (HF diet) or regular chow diet (control) for 6,8,14 or 28 days. n=3–4 mice/group, *p<0.05, **p<0.01 vs. control as determined by
Student's t test. The gel below the graph represents RT-PCR detection of the NOX4 transcript from the same mice. (F) Comparison of NOX4 mRNA expression
between control mice and mice with fat specific ablation of the insulin receptor (FIRKO) as in (E). n=5 mice/group, n.s.=non significant. Fat-specific insulin receptor
knock-out mice [49] were kept at the animal facility of Joslin Diabetes Center (Boston, MA) according to the guidelines of the local Ethical Committee.
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periods of 6, 8, 14 and 28 days. As shown in Fig. 9E, short term
diet was linked to an increase in adipose tissue NOX4 mRNA
content. As the duration of the high fat diet and the real-time
PCR primers applied in the study of Furukawa et al. mentioned
above were not indicated we cannot directly compare our results,
however the magnitude of changes (∼2 fold) correlates with our
findings. Noteworthy, however, that in our experiment no change
in NOX4 mRNA expression was observed when comparing the
shortest and longest period (6 and 28 days, respectively), in-
dicating again a distance between the development of insulin
resistance and whole adipose tissue NOX4 mRNA content.
The most straightforward way of relating adipose tissue
insulin resistance to NOX4 expression is to compare NOX4
mRNA levels between mice with fat tissue specific ablation of
the insulin receptor (FIRKO mice) and their littermates carrying
only the flox allele. FIRKO mice lack insulin signaling in
adipose tissue, exhibit reduced fat mass with heterogenicity of
cell size and are protected from obesity and obesity related
glucose intolerance [49]. WAT of FIRKO mice contained
slightly decreased amount of NOX4 when compared to control,
however this change was not statistically significant (Fig. 9F).
Taken together all the above in vivo data they indicate that
while NOX4-deficient adipocyte cell lines show impaired
insulin signaling [23], the NOX4 content of whole adipose
tissue does not directly correlate with insulin sensitivity but
rather changes in the ratio between the stromal/vascular fraction
and adipocytes or in the “differentiation stage” of the adipose
tissue as shown in the mice challenged by short term high fat
diet. Adipose tissue is a remarkably active tissue with a high
remodelling capacity. In this adaptative remodelling the
interaction between endothelial cells and preadipocytes plays
an important role as demonstrated by a recent study where
blocking of vascular endothelial growth factor (VEGF) receptor
resulted in decreased angiogenesis with a concomitant inhibition
of adipocyte differentiation [53]. As endothelial cell and
preadipocytes both express high levels of NOX4 mRNA their
contribution to the whole tissue NOX4mRNA content should be
taken into consideration.
In summary, our study investigated the regulation of NOX4,
an NADPH oxidase enzyme during adipogenesis in in vitro
models of white and brown adipocytes. Our results suggest that
NOX4 mRNA is regulated during adipogenesis in the same
fashion as antiadipogenic molecules. Protein expression did not
always correlate with the alterations in gene transcription,
evoking a tight and complex regulatory mechanism and
reinforcing the notion about the importance of NOX4 in
adipogenesis. Using animal models we demonstrate that in vivo
whole adipose tissue NOX4 content is not directly linked to
insulin resistance but should rather be viewed as a hallmark for
relative adipocyte mass and differentiation.
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